SCHEMBL7221992

SCHEMBL7221992

CC(C)Oc1ccc(N(C)CCC2(O)CCN(C(=O)Cc3ccccc3Cl)CC2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
MAPK1 P28482 1/20 0.42
OPRM1 P35372 1/20 0.41
OPRD1 P41143 1/20 0.41
OPRK1 P41145 1/20 0.41
GHSR Q92847 1/20 0.39
HTT P42858 1/20 0.39
MBTPS1 Q14703 1/20 0.39
KMT2A Q03164 4/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 3/20 0.38
DRD2 P14416 2/20 0.36
DRD3 P35462 2/20 0.36
TP53 P04637 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
LMNA P02545 1/20 0.35
RAB9A P51151 1/20 0.35
TACR2 P21452 1/20 0.35
TACR1 P25103 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7231823 0.90 OPRD1 (0.40) ALDH1A1OPRD1OPRK1KMT2AKDM4E
SCHEMBL7229778 0.89 KMT2A (0.38) ALDH1A1OPRD1OPRK1KMT2AMEN1
SCHEMBL7223661 0.89 OPRD1 (0.41) ALDH1A1OPRD1OPRK1GHSRMBTPS1
SCHEMBL7222289 0.87 RBP4 (0.41) ALDH1A1OPRD1OPRK1KMT2AMEN1
SCHEMBL7231689 0.86 KMT2A (0.42) ALDH1A1OPRK1KMT2AKDM4EMEN1
SCHEMBL7230028 0.85 CYP3A4 (0.44) OPRM1OPRD1OPRK1KMT2AMEN1
SCHEMBL6782827 0.85 GAA (0.41) ALDH1A1OPRM1OPRD1GHSRMBTPS1
Hydrochloric Acid SCHEMBL6785737 0.84 GAA (0.40) ALDH1A1OPRM1OPRD1GHSRMBTPS1
SCHEMBL7223175 0.84 OPRD1 (0.46) OPRM1OPRD1OPRK1MBTPS1KMT2A
SCHEMBL7221710 0.83 KCNH2 (0.42) MBTPS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6642257-B2 Fewer side-effects than do the conventional analgesics; 4-hydroxypiperidine derivatives MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2003-11-04 US disclosed
US-20020049229-A1 Agents for treating neuropathic pain MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2002-04-25 US disclosed
EP-1182193-A1 REMEDIES FOR NEUROPATHIC PAIN MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2002-02-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020049229-A1 Agents for treating neuropathic pain OPRM1, OPRK1, OPRL1 ALDH1A1 310/4885MAPK1 1574/4885OPRM1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.